Skip to main content
    T

    Tilray Inc (TLRY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.34
    -0.09 (-3.70%)

    Market Cap: $359.12M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tilray Inc (TLRY) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Tilray (TLRY) to earn -$0.13 per share in the fiscal year ending May 31, 2027, on revenue of $1.10B. Of 10 analysts, 3 rate the stock Buy or Strong Buy, 7 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending May 31, 2027 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.70, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 30% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy330.0%
    Hold770.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 5.5%.

    Fiscal year ending May 31, 2027
    -$0.13
    EPS consensus, revenue $1.10B
    Fiscal year ending May 31, 2028
    $0.14
    EPS consensus, revenue $1.16B
    Next report
    Jan 6, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    May 31, 2027-$0.13-$0.36 to $0.102$1.10B$1.07B to $1.13B10
    May 31, 2028$0.14-$0.11 to $0.392$1.16B$1.11B to $1.20B9

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    May 31, 2027-$0.02-$0.08 to $0.008$321.91M$286.16M to $382.41M11

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending May 31, 202701
    Fiscal year ending May 31, 202801

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending May 31, 2027 has turned from a profit of $0.26 to a loss.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending May 31, 2027-$0.13$0.06$0.07$0.26$0.26N/A
    Fiscal year ending May 31, 2028$0.14$0.18$0.18$0.45$0.74-80.8%

    Frequently Asked Questions About TLRY

    What is the TLRY stock forecast?

    Consensus analyst estimates put Tilray's EPS at -$0.13 for the fiscal year ending May 31, 2027, on revenue of $1.10B. The consensus rating from 10 analysts is Hold.

    How do analysts rate TLRY stock?

    Of 10 analysts covering Tilray, 0 rate it Strong Buy, 3 Buy, 7 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from TLRY next year?

    For the fiscal year ending May 31, 2027, the consensus EPS estimate is -$0.13, with estimates from -$0.36 to $0.10 from 2 analysts. For the fiscal year ending May 31, 2028, the consensus EPS estimate is $0.14, with estimates from -$0.11 to $0.39 from 2 analysts.

    What revenue do analysts expect from Tilray next year?

    For the fiscal year ending May 31, 2027, the consensus revenue estimate is $1.10B, with estimates from $1.07B to $1.13B. For the fiscal year ending May 31, 2028, the consensus revenue estimate is $1.16B, with estimates from $1.11B to $1.20B.

    How many analysts cover TLRY?

    10 analysts rate Tilray stock, and 2 analysts estimate its EPS for the fiscal year ending May 31, 2027.